A Study of Different Doses of Sitagliptin (MK-0431) in Participants With Type 2 Diabetes Mellitus (MK-0431-014)

NCT00481663 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

555

Enrollment

INDUSTRY

Sponsor class

Conditions

Type II Diabetes Mellitus

Interventions

DRUG: Sitagliptin
DRUG: Placebo to sitagliptin
DRUG: Metformin
DRUG: Rescue

Sponsor

Merck Sharp & Dohme LLC